Switch theme
Sign up to access all valuation multiples
Geratherm Medical AG is a Germany-based medical technology company. The firm operates through four segments: Healthcare Diagnostic, Medical Warming Systems, Cardio/Stroke and Respiratory. Healthcare Diagnostic segment which generates majority revenue provides analog and digital products for measuring body temperature, blood pressure monitors and other products for measuring temperature, as well as related accessories. Medical Warming Systems offers solutions for temperature management at all stages in the pre-clinical and clinical care of the patients, such as rescue situations and operations. Cardio/Stroke segment comprises products for preventing strokes. The Respiratory segment focuses on the development and production of products for pulmonary functional diagnostics.
1990
226
Last FY Revenue $25.0M
Last FY EBITDA $4.7M
$19.5M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Geratherm Medical achieved revenue of $25.0M and an EBITDA of $4.7M.
Geratherm Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Geratherm Medical valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $25.0M | XXX | XXX | XXX |
| Gross Profit | XXX | $20.0M | XXX | XXX | XXX |
| Gross Margin | XXX | 80% | XXX | XXX | XXX |
| EBITDA | XXX | $4.7M | XXX | XXX | XXX |
| EBITDA Margin | XXX | 19% | XXX | XXX | XXX |
| EBIT | XXX | $3.6M | XXX | XXX | XXX |
| EBIT Margin | XXX | 14% | XXX | XXX | XXX |
| Net Profit | XXX | $1.2M | XXX | XXX | XXX |
| Net Margin | XXX | 5% | XXX | XXX | XXX |
| Net Debt | XXX | $2.2M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Geratherm Medical's stock price is EUR 3 (or $4).
Geratherm Medical has current market cap of EUR 17.1M (or $19.2M), and EV of EUR 17.3M (or $19.5M).
See Geratherm Medical trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $19.5M | $19.2M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Geratherm Medical has market cap of $19.2M and EV of $19.5M.
Geratherm Medical's trades at 0.8x EV/Revenue multiple, and 4.1x EV/EBITDA.
Equity research analysts estimate Geratherm Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Geratherm Medical's P/E ratio is not available.
See valuation multiples for Geratherm Medical and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $19.2M | XXX | $19.2M | XXX | XXX | XXX |
| EV (current) | $19.5M | XXX | $19.5M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 0.8x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | 4.1x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | 5.4x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | 15.4x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -101.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialGeratherm Medical's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Geratherm Medical's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Geratherm Medical's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Geratherm Medical and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | 19% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 7% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 66% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Geratherm Medical acquired XXX companies to date.
Last acquisition by Geratherm Medical was XXXXXXXX, XXXXX XXXXX XXXXXX . Geratherm Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Geratherm Medical founded? | Geratherm Medical was founded in 1990. |
| Where is Geratherm Medical headquartered? | Geratherm Medical is headquartered in Germany. |
| How many employees does Geratherm Medical have? | As of today, Geratherm Medical has 226 employees. |
| Is Geratherm Medical publicy listed? | Yes, Geratherm Medical is a public company listed on ETR. |
| What is the stock symbol of Geratherm Medical? | Geratherm Medical trades under GME ticker. |
| When did Geratherm Medical go public? | Geratherm Medical went public in 2000. |
| Who are competitors of Geratherm Medical? | Similar companies to Geratherm Medical include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Geratherm Medical? | Geratherm Medical's current market cap is $19.2M |
| Is Geratherm Medical profitable? | Yes, Geratherm Medical is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
